BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 23131553)

  • 21. Altered localization, abnormal modification and loss of function of Sigma receptor-1 in amyotrophic lateral sclerosis.
    Prause J; Goswami A; Katona I; Roos A; Schnizler M; Bushuven E; Dreier A; Buchkremer S; Johann S; Beyer C; Deschauer M; Troost D; Weis J
    Hum Mol Genet; 2013 Apr; 22(8):1581-600. PubMed ID: 23314020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Over-expression of Hsp27 does not influence disease in the mutant SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Krishnan J; Vannuvel K; Andries M; Waelkens E; Robberecht W; Van Den Bosch L
    J Neurochem; 2008 Sep; 106(5):2170-83. PubMed ID: 18624915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel monoclonal antibody reveals a conformational alteration shared by amyotrophic lateral sclerosis-linked SOD1 mutants.
    Fujisawa T; Homma K; Yamaguchi N; Kadowaki H; Tsuburaya N; Naguro I; Matsuzawa A; Takeda K; Takahashi Y; Goto J; Tsuji S; Nishitoh H; Ichijo H
    Ann Neurol; 2012 Nov; 72(5):739-49. PubMed ID: 23280792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endoplasmic reticulum stress is accompanied by activation of NF-κB in amyotrophic lateral sclerosis.
    Prell T; Lautenschläger J; Weidemann L; Ruhmer J; Witte OW; Grosskreutz J
    J Neuroimmunol; 2014 May; 270(1-2):29-36. PubMed ID: 24666819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of STAT3 and inhibitory effects of pioglitazone on STAT3 activity in a mouse model of SOD1-mutated amyotrophic lateral sclerosis.
    Shibata N; Yamamoto T; Hiroi A; Omi Y; Kato Y; Kobayashi M
    Neuropathology; 2010 Aug; 30(4):353-60. PubMed ID: 19925559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcium-permeable AMPA receptors promote misfolding of mutant SOD1 protein and development of amyotrophic lateral sclerosis in a transgenic mouse model.
    Tateno M; Sadakata H; Tanaka M; Itohara S; Shin RM; Miura M; Masuda M; Aosaki T; Urushitani M; Misawa H; Takahashi R
    Hum Mol Genet; 2004 Oct; 13(19):2183-96. PubMed ID: 15294873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of glial fibrillary acidic protein marginally accelerates disease progression in a SOD1(H46R) transgenic mouse model of ALS.
    Yoshii Y; Otomo A; Pan L; Ohtsuka M; Hadano S
    Neurosci Res; 2011 Jul; 70(3):321-9. PubMed ID: 21453731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of thymic stimulation of CD4+ T cell expansion on disease onset and progression in mutant SOD1 mice.
    Sheean RK; Weston RH; Perera ND; D'Amico A; Nutt SL; Turner BJ
    J Neuroinflammation; 2015 Feb; 12():40. PubMed ID: 25889790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutant SOD1-induced neuronal toxicity is mediated by increased mitochondrial superoxide levels.
    Zimmerman MC; Oberley LW; Flanagan SW
    J Neurochem; 2007 Aug; 102(3):609-18. PubMed ID: 17394531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glutamate release induced by activation of glycine and GABA transporters in spinal cord is enhanced in a mouse model of amyotrophic lateral sclerosis.
    Raiteri L; Zappettini S; Stigliani S; Paluzzi S; Raiteri M; Bonanno G
    Neurotoxicology; 2005 Oct; 26(5):883-92. PubMed ID: 15885796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bromocriptine methylate suppresses glial inflammation and moderates disease progression in a mouse model of amyotrophic lateral sclerosis.
    Tanaka K; Kanno T; Yanagisawa Y; Yasutake K; Hadano S; Yoshii F; Ikeda JE
    Exp Neurol; 2011 Nov; 232(1):41-52. PubMed ID: 21867702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel mouse model with impaired dynein/dynactin function develops amyotrophic lateral sclerosis (ALS)-like features in motor neurons and improves lifespan in SOD1-ALS mice.
    Teuling E; van Dis V; Wulf PS; Haasdijk ED; Akhmanova A; Hoogenraad CC; Jaarsma D
    Hum Mol Genet; 2008 Sep; 17(18):2849-62. PubMed ID: 18579581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolonged survival and milder impairment of motor function in the SOD1 ALS mouse model devoid of fibroblast growth factor 2.
    Thau N; Jungnickel J; Knippenberg S; Ratzka A; Dengler R; Petri S; Grothe C
    Neurobiol Dis; 2012 Aug; 47(2):248-57. PubMed ID: 22542539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bcl2-A1 interacts with pro-caspase-3: implications for amyotrophic lateral sclerosis.
    Iaccarino C; Mura ME; Esposito S; Carta F; Sanna G; Turrini F; Carrì MT; Crosio C
    Neurobiol Dis; 2011 Sep; 43(3):642-50. PubMed ID: 21624464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic ablation of IP3 receptor 2 increases cytokines and decreases survival of SOD1G93A mice.
    Staats KA; Humblet-Baron S; Bento-Abreu A; Scheveneels W; Nikolaou A; Deckers K; Lemmens R; Goris A; Van Ginderachter JA; Van Damme P; Hisatsune C; Mikoshiba K; Liston A; Robberecht W; Van Den Bosch L
    Hum Mol Genet; 2016 Aug; 25(16):3491-3499. PubMed ID: 27378687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of the PPARgamma activator pioglitazone on p38 MAP kinase and IkappaBalpha in the spinal cord of a transgenic mouse model of amyotrophic lateral sclerosis.
    Shibata N; Kawaguchi-Niida M; Yamamoto T; Toi S; Hirano A; Kobayashi M
    Neuropathology; 2008 Aug; 28(4):387-98. PubMed ID: 18312546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevation of the Hsp70 chaperone does not effect toxicity in mouse models of familial amyotrophic lateral sclerosis.
    Liu J; Shinobu LA; Ward CM; Young D; Cleveland DW
    J Neurochem; 2005 May; 93(4):875-82. PubMed ID: 15857390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The voltage-gated calcium channel blocker lomerizine is neuroprotective in motor neurons expressing mutant SOD1, but not TDP-43.
    Tran LT; Gentil BJ; Sullivan KE; Durham HD
    J Neurochem; 2014 Aug; 130(3):455-66. PubMed ID: 24716897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The proinflammatory action of microglial P2 receptors is enhanced in SOD1 models for amyotrophic lateral sclerosis.
    D'Ambrosi N; Finocchi P; Apolloni S; Cozzolino M; Ferri A; Padovano V; Pietrini G; Carrì MT; Volonté C
    J Immunol; 2009 Oct; 183(7):4648-56. PubMed ID: 19734218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TDP-43 physically interacts with amyotrophic lateral sclerosis-linked mutant CuZn superoxide dismutase.
    Higashi S; Tsuchiya Y; Araki T; Wada K; Kabuta T
    Neurochem Int; 2010 Dec; 57(8):906-13. PubMed ID: 20933032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.